Galderma Group AG
Study to Evaluate Satisfaction After Treatment With Restylane
- Conditions
- Cheek Augmentation
- Interventions
- Device: Restylane VolymeDevice: Restylane Lyft Lidocaine
- First Posted Date
- 2020-11-20
- Last Posted Date
- 2024-03-06
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 60
- Registration Number
- NCT04638816
- Locations
- 🇨🇦
Galderma Study Site, Montreal, Quebec, Canada
New Dermal Filler for Chin Correction and Augmentation
- Conditions
- Chin Augmentation and Correction
- Interventions
- Device: Hyaluronic Acid
- First Posted Date
- 2020-11-17
- Last Posted Date
- 2022-08-25
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 140
- Registration Number
- NCT04631263
- Locations
- 🇨🇦
Galderma Research Site, Westmount, Quebec, Canada
Open Label Extension for 43USSA1812
- Conditions
- CheekWrinkle
- Interventions
- Device: Sculptra Aethestic reconsituted with 8ml Sterile Water for Injection
- First Posted Date
- 2020-10-20
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 111
- Registration Number
- NCT04595331
- Locations
- 🇺🇸
Galderma Research Site, Spring, Texas, United States
🇺🇸Galderma Research site, San Diego, California, United States
A Study to Assess the Effects of Nemolizumab on Cytochrome P450 Substrates in Participants With Moderate-to-Severe Atopic Dermatitis
- First Posted Date
- 2020-09-24
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 17
- Registration Number
- NCT04562116
- Locations
- 🇺🇸
8894 Galderma Investigational Site, North Hollywood, California, United States
🇺🇸9954 Galderma Investigational Site, Hallandale Beach, Florida, United States
🇺🇸9923 Galderma Investigational Site, Miami, Florida, United States
Restylane Defyne in a Stepwise Treatment Approach
- Conditions
- Lower Face Folds and Lines
- Interventions
- Device: Restylane Defyne
- First Posted Date
- 2020-08-20
- Last Posted Date
- 2023-04-14
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 62
- Registration Number
- NCT04520997
- Locations
- 🇮🇹
Galderma Research Site, Palermo, Italy
A Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)
- First Posted Date
- 2020-08-06
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 274
- Registration Number
- NCT04501679
- Locations
- 🇨🇭
Galderma Investigational Site, Weinfelden, Switzerland
Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)
- First Posted Date
- 2020-08-06
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 286
- Registration Number
- NCT04501666
- Locations
- 🇬🇧
Galderma Investigational Site, Newcastle Upon Tyne, United Kingdom
A Study to Compare Efficacy and Safety of Trifarotene Cream When Used With an Oral Antibiotic for the Treatment of Severe Acne Vulgaris (AV)
- Conditions
- Acne Vulgaris
- Interventions
- First Posted Date
- 2020-06-30
- Last Posted Date
- 2022-05-10
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 202
- Registration Number
- NCT04451330
- Locations
- 🇵🇷
Galderma Investigational Site, Aibonito, Puerto Rico
A Study to Assess Immunization Responses in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Treated With Nemolizumab
- First Posted Date
- 2020-04-28
- Last Posted Date
- 2025-06-05
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 242
- Registration Number
- NCT04365387
- Locations
- 🇺🇸
Galderma Investigational Site (Site#8213), Ormond Beach, Florida, United States
🇺🇸Galderma Investigational Site (Site#8428), Philadelphia, Pennsylvania, United States
🇺🇸Galderma Investigational Site (Site#9922), Phoenix, Arizona, United States
A Study to Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier Study
- Conditions
- Keratosis, Actinic
- Interventions
- Drug: MAL CreamDrug: Vehicle cream
- First Posted Date
- 2020-02-13
- Last Posted Date
- 2023-10-10
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 125
- Registration Number
- NCT04269395
- Locations
- 🇺🇸
Galderma Investigational Site (Site#8447), Fort Smith, Arkansas, United States
🇺🇸Galderma Investigational Site (Site#8577), Encinitas, California, United States
🇺🇸Galderma Investigational Site (Site#8636), Fountain Valley, California, United States